Stocks and InvestingStocks and Investing
Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022

Salveen Richter Maintained (ALLO) at Hold with Decreased Target to $12 on, Mar 7th, 2022


Published on 2024-10-27 19:59:00 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Allogene Therapeutics, Inc." (ALLO) at Hold with Decreased Target from $20 to $12 on, Mar 7th, 2022.

Salveen has made no other calls on ALLO in the last 4 months.



There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, 0 agree with Salveen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Salveen


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Tuesday, December 14th, 2021